Department of Surgery Archive
-
September 8, 2022
Study tests drug to illuminate cancer during surgery
A Vanderbilt study is testing drugs that provide a targeted fluorescent dye that clings to and illuminates cancer. -
September 1, 2022
Grant supports research to study gastric cancer origins
Vanderbilt researchers have received $5 million in funding from a new initiative by the National Cancer Institute that aims to define how gastric and gastroesophageal junction adenocarcinomas form and evolve at the cellular level. -
August 31, 2022
After a career of service to others, Raiford to retire
-
August 25, 2022
New high-tech biobank safeguards critical specimens
-
July 21, 2022
Researchers find potential new target against colorectal cancer
-
July 14, 2022
Pediatric ECMO program founder Pietsch retires
John Pietsch, MD, the recently retired founder of the extracorporeal membrane oxygenation (ECMO) program at Monroe Carell Jr. Children’s Hospital at Vanderbilt, didn’t grow up wanting to be a doctor. -
June 23, 2022
Study reveals how gastric cancer forms, suggests preventive treatment
Eunyoung Choi, PhD, assistant professor of Surgery, and colleagues identified for the first time that Trop2+/CD133+/CD166+ dysplastic stem cells are a key source of clonal evolution of dysplasia to multiple types of gastric cancer.